Using peripheral blood mononuclear cells from an independent cohort of 140 patients, the authors showed that circulating TET2 was significantly downregulated in 86% of PAH patients and was associated with increased inflammation. This evidence concerns the gene TET2 and pulmonary arterial hypertension.